Arcadia Biosciences, Inc.
RKDA
$3.15
$0.155.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.41M | 5.26M | 5.05M | 4.61M | 4.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.41M | 5.26M | 5.05M | 4.61M | 4.37M |
| Cost of Revenue | 3.26M | 3.07M | 2.87M | 2.20M | 1.98M |
| Gross Profit | 2.15M | 2.19M | 2.18M | 2.41M | 2.39M |
| SG&A Expenses | 8.75M | 9.31M | 9.63M | 8.68M | 8.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.01M | 12.38M | 12.50M | 10.88M | 10.28M |
| Operating Income | -6.61M | -7.13M | -7.46M | -6.27M | -5.91M |
| Income Before Tax | -7.07M | -762.00K | -4.31M | -724.00K | -181.00K |
| Income Tax Expenses | 8.00K | 8.00K | 8.00K | 7.00K | 7.00K |
| Earnings from Continuing Operations | -7.08 | -0.77 | -4.32 | -0.73 | -0.19 |
| Earnings from Discontinued Operations | -457.00K | -1.25M | -2.72M | -5.10M | -6.59M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 0.00 | 0.00 |
| Net Income | -7.54M | -2.02M | -7.04M | -5.83M | -6.78M |
| EBIT | -6.61M | -7.13M | -7.46M | -6.27M | -5.91M |
| EBITDA | -6.55M | -7.05M | -7.34M | -6.12M | -5.68M |
| EPS Basic | -5.52 | -1.48 | -5.16 | -4.28 | -4.98 |
| Normalized Basic EPS | -4.42 | -2.91 | -3.72 | -2.03 | -1.79 |
| EPS Diluted | -5.52 | -1.93 | -5.61 | -4.73 | -5.43 |
| Normalized Diluted EPS | -3.24 | -2.35 | -3.16 | -1.47 | -1.22 |
| Average Basic Shares Outstanding | 5.46M | 5.46M | 5.45M | 5.45M | 5.45M |
| Average Diluted Shares Outstanding | 6.70M | 7.27M | 7.27M | 7.27M | 7.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |